Mycochemicals Against Cancer Stem Cells

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2023 Jun 27

PMID 37368660

Authors

Massimo Tacchini

Gianni Sacchetti

Alessandra Guerrini

Guglielmo Paganetto

Affiliations

Soon will be listed here.

Abstract

Since ancient times, mushrooms have been considered valuable allies of human well-being both from a dietary and medicinal point of view. Their essential role in several traditional medicines is explained today by the discovery of the plethora of biomolecules that have shown proven efficacy for treating various diseases, including cancer. Numerous studies have already been conducted to explore the antitumoural properties of mushroom extracts against cancer. Still, very few have reported the anticancer properties of mushroom polysaccharides and mycochemicals against the specific population of cancer stem cells (CSCs). In this context, β-glucans are relevant in modulating immunological surveillance against this subpopulation of cancer cells within tumours. Small molecules, less studied despite their spread and assortment, could exhibit the same importance. In this review, we discuss several pieces of evidence of the association between β-glucans and small mycochemicals in modulating biological mechanisms which are proven to be involved with CSCs development. Experimental evidence and an in silico approach are evaluated with the hope of contributing to future strategies aimed at the direct study of the action of these mycochemicals on this subpopulation of cancer cells.

Citing Articles

Cues from evolving insights about Cancer stem cells to tackle cancer metastases.

J Stem Cells Regen Med. 2024; 19(2):27-28.

PMID: 38406615 PMC: 10891314. DOI: 10.46582/jsrm.1902006.

The emerging role of oral microbiota in oral cancer initiation, progression and stemness.

Saikia P, Pathak L, Mitra S, Das B Front Immunol. 2023; 14:1198269.

PMID: 37954619 PMC: 10639169. DOI: 10.3389/fimmu.2023.1198269.

References

Wu J, Doonan B, Hsieh T, Yang Q, Yang X, Ling M . Recent Advances and Challenges in Studies of Control of Cancer Stem Cells and the Gut Microbiome by the Trametes-Derived Polysaccharopeptide PSP (Review). Int J Med Mushrooms. 2016; 18(8):651-660. DOI: 10.1615/IntJMedMushrooms.v18.i8.10. View

Geethangili M, Tzeng Y . Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds. Evid Based Complement Alternat Med. 2009; 2011:212641. PMC: 3095428. DOI: 10.1093/ecam/nep108. View

Mishra V, Tomar S, Yadav P, Singh M . Promising anticancer activity of polysaccharides and other macromolecules derived from oyster mushroom (Pleurotus sp.): An updated review. Int J Biol Macromol. 2021; 182:1628-1637. DOI: 10.1016/j.ijbiomac.2021.05.102. View

Lederer M, Bley N, Schleifer C, Huttelmaier S . The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer. Semin Cancer Biol. 2014; 29:3-12. DOI: 10.1016/j.semcancer.2014.07.006. View

Ina K, Furuta R, Kataoka T, Kayukawa S, Ina H, Yoneda M . Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases. Med Sci (Basel). 2017; 4(2). PMC: 5635777. DOI: 10.3390/medsci4020008. View

Nakamura K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M . Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res. 2006; 26(1A):43-7. View

WALKER E, Pacold M, Perisic O, Stephens L, Hawkins P, Wymann M . Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell. 2000; 6(4):909-19. DOI: 10.1016/s1097-2765(05)00089-4. View

Toft-Petersen M, Nederby L, Kjeldsen E, Kerndrup G, Brown G, Hokland P . Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome. Br J Haematol. 2016; 175(3):393-401. PMC: 5091626. DOI: 10.1111/bjh.14270. View

Ma J, Qin L, Li X . Role of STAT3 signaling pathway in breast cancer. Cell Commun Signal. 2020; 18(1):33. PMC: 7048131. DOI: 10.1186/s12964-020-0527-z. View

10.

Lau E, Ho N, Lee T . Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications. Stem Cells Int. 2017; 2017:3714190. PMC: 5346399. DOI: 10.1155/2017/3714190. View

11.

Sylla B, Legentil L, Saraswat-Ohri S, Vashishta A, Daniellou R, Wang H . Oligo-β-(1 → 3)-glucans: impact of thio-bridges on immunostimulating activities and the development of cancer stem cells. J Med Chem. 2014; 57(20):8280-92. DOI: 10.1021/jm500506b. View

12.

Downward J . Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003; 3(1):11-22. DOI: 10.1038/nrc969. View

13.

Lee Y, Park S, Kim Y, Lee W, Park O . AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin. Exp Mol Med. 2009; 41(3):201-7. PMC: 2679247. DOI: 10.3858/emm.2009.41.3.023. View

14.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

15.

Zhong Y, Li X, Yao H, Lin K . The Characteristics of PD-L1 Inhibitors, from Peptides to Small Molecules. Molecules. 2019; 24(10). PMC: 6572691. DOI: 10.3390/molecules24101940. View

16.

Gastaldi S, Sassi F, Accornero P, Torti D, Galimi F, Migliardi G . Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. Oncogene. 2012; 32(11):1428-40. DOI: 10.1038/onc.2012.154. View

17.

Lenzi M, Cocchi V, Novakovic A, Karaman M, Sakac M, Mandic A . Meripilus giganteus ethanolic extract exhibits pro-apoptotic and anti-proliferative effects in leukemic cell lines. BMC Complement Altern Med. 2018; 18(1):300. PMC: 6233556. DOI: 10.1186/s12906-018-2366-7. View

18.

Zaidi A, Kosovec J, Matsui D, Omstead A, Raj M, Rao R . PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model. Ann Surg. 2016; 266(1):91-98. DOI: 10.1097/SLA.0000000000001908. View

19.

Brembeck F, Schwarz-Romond T, Bakkers J, Wilhelm S, Hammerschmidt M, Birchmeier W . Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev. 2004; 18(18):2225-30. PMC: 517514. DOI: 10.1101/gad.317604. View

20.

Lazennec G, Lam P . Recent discoveries concerning the tumor - mesenchymal stem cell interactions. Biochim Biophys Acta. 2016; 1866(2):290-299. DOI: 10.1016/j.bbcan.2016.10.004. View